Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies - Additional Information (Details)

v2.4.0.8
Summary of Significant Accounting Policies - Additional Information (Details) (USD $)
In Thousands, except Share data, unless otherwise specified
0 Months Ended 3 Months Ended 9 Months Ended 9 Months Ended 0 Months Ended 3 Months Ended 9 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended 9 Months Ended
Nov. 11, 2013
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2014
Segment
Product
Sep. 30, 2013
Mar. 07, 2014
Feb. 20, 2014
Dec. 31, 2013
Dec. 31, 2012
Sep. 30, 2014
Common Stock
Feb. 20, 2014
Inogen, Inc.
Feb. 20, 2014
Stockholders
Sep. 30, 2014
Accounts Receivable
Dec. 31, 2013
Accounts Receivable
Sep. 30, 2014
Customer Concentration Risk
Medicare Service Reimbursement Programs
Compared to Rental Revenue
Sep. 30, 2013
Customer Concentration Risk
Medicare Service Reimbursement Programs
Compared to Rental Revenue
Sep. 30, 2014
Customer Concentration Risk
Medicare Service Reimbursement Programs
Compared to Rental Revenue
Sep. 30, 2013
Customer Concentration Risk
Medicare Service Reimbursement Programs
Compared to Rental Revenue
Sep. 30, 2014
Customer Concentration Risk
Medicare Service Reimbursement Programs
Compared to Total Revenue
Sep. 30, 2013
Customer Concentration Risk
Medicare Service Reimbursement Programs
Compared to Total Revenue
Sep. 30, 2014
Customer Concentration Risk
Medicare Service Reimbursement Programs
Compared to Total Revenue
Sep. 30, 2013
Customer Concentration Risk
Medicare Service Reimbursement Programs
Compared to Total Revenue
Sep. 30, 2014
Credit Concentration Risk
Medicare Service Reimbursement Programs
Compared to Total Accounts Receivable
Dec. 31, 2013
Credit Concentration Risk
Medicare Service Reimbursement Programs
Compared to Total Accounts Receivable
Sep. 30, 2014
vendor one
raw materials
Sep. 30, 2013
vendor one
raw materials
Sep. 30, 2014
vendor one
Vendor Two
Sep. 30, 2013
vendor one
Vendor Two
Sep. 30, 2014
vendor one
Vendor Three
Sep. 30, 2013
vendor one
Vendor Three
Sep. 30, 2014
Maximum
Customer Concentration Risk
Total revenue
Single Customer
Sep. 30, 2013
Maximum
Customer Concentration Risk
Total revenue
Single Customer
Sep. 30, 2014
Service Contracts
Significant Accounting Policies [Line Items]                                                                  
Extended service contracts       Lifetime of the patient                                                         12 to 24 months
Accrual of product warranty liability   $ 1,172   $ 1,172       $ 809 $ 447                                                
Number of deliverables qualifying as separate units       2                                                          
Deliverable standard warranty, period       3 years                                                          
Estimation for sale of products       The Company estimates that 60% of patients will succumb to their disease within three years. Given the approximate mortality rate of 20% per year, the Company estimates on average all patients will succumb to their disease within five years.                                                          
Rental revenue earned       30-day period                                                          
Unbilled Receivables   3,410   3,410       1,435                                                  
Concentration risk, percentage                             78.60% 70.80% 74.30% 73.10% 26.70% 27.40% 25.60% 28.80% 20.30% 25.00% 18.80% 15.70% 17.80% 14.90% 8.00% 8.60% 10.00% 10.00%  
Accounts Receivable Net Current   18,061   18,061       10,231         3,661 2,560                                      
Cost Of Property Repairs And Maintenance   367 251 1,157 707                                                        
Property Plant And Equipment Salvage Value   $ 0   $ 0                                                          
Number Of Operating Segments       1                                                          
Reverse stock split ratio 3:1                                                                
Effective date of reverse stock split       Nov. 12, 2013                                                          
Common stock, par value   $ 0.001   $ 0.001     $ 16.00 $ 0.001                                                  
Common stock, shares issued   18,436,802   18,436,802     4,411,763 280,974                                                  
Number of shares sold                     3,529,411 882,352                                          
Common stock purchased by underwriters           99,550                                                      
Conversion of preferred stock, shares                   14,259,647